Israel Englander Sangamo Therapeutics, Inc Transaction History

Millennium Management LLC

$192 Billion
Q2 2025

A detailed history of Israel Englander (Millennium Management LLC) transactions in Sangamo Therapeutics, Inc stock. As of the latest transaction made, Millennium Management LLC holds 364,147 shares of SGMO stock, worth $189,356. This represents 0.0% of its overall portfolio holdings.

Number of Shares

364,147

Previous 229,400 58.74%

Holding current value

$189,356

Previous $151,000 29.8%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$0.43 - $0.81 $347,416 - $654,435	-807,945 Reduced 68.93%	364,147 $196,000
Q1 2025 May 15, 2025	SELL	$0.66 - $1.37 $1.03 Million - $2.15 Million	-1,567,574 Reduced 57.22%	1,172,092 $773,000
Q4 2024 Feb 14, 2025	BUY	$0.78 - $2.87 $646,102 - $2.38 Million	828,337 Added 43.34%	2,739,666 $2.79 Million
Q3 2024 Nov 14, 2024	SELL	$0.32 - $1.1 $158,997 - $546,554	-496,868 Reduced 20.63%	1,911,329 $1.64 Million
Q2 2024 Aug 14, 2024	BUY	$0.36 - $0.65 $469,195 - $847,158	1,303,320 Added 117.96%	2,408,197 $866,000
Q1 2024 May 15, 2024	SELL	$0.42 - $1.38 $7,443 - $24,456	-17,722 Reduced 1.58%	1,104,877 $740,000
Q4 2023 Feb 14, 2024	BUY	$0.3 - $0.63 $61,543 - $129,241	205,145 Added 22.36%	1,122,599 $606,000
Q2 2023 Aug 14, 2023	BUY	$1.11 - $1.74 $676,124 - $1.06 Million	609,121 Added 197.55%	917,454 $1.19 Million
Q1 2023 May 15, 2023	BUY	$1.66 - $3.67 $159,897 - $353,509	96,324 Added 45.43%	308,333 $543,000
Q4 2022 Feb 14, 2023	SELL	$2.77 - $5.07 $1.14 Million - $2.09 Million	-413,188 Reduced 66.09%	212,009 $666,000
Q3 2022 Nov 14, 2022	SELL	$4.27 - $6.39 $2.48 Million - $3.71 Million	-581,055 Reduced 48.17%	625,197 $3.06 Million
Q2 2022 Aug 15, 2022	BUY	$3.28 - $6.21 $1.69 Million - $3.2 Million	515,625 Added 74.66%	1,206,252 $4.99 Million
Q1 2022 May 16, 2022	SELL	$5.23 - $7.82 $3.21 Million - $4.8 Million	-613,227 Reduced 47.03%	690,627 $4.01 Million
Q4 2021 Feb 14, 2022	BUY	$7.29 - $10.97 $8.05 Million - $12.1 Million	1,104,235 Added 553.17%	1,303,854 $9.78 Million
Q3 2021 Nov 15, 2021	BUY	$9.01 - $12.01 $376,329 - $501,633	41,768 Added 26.46%	199,619 $1.8 Million
Q2 2021 Aug 16, 2021	BUY	$10.17 - $12.64 $425,899 - $529,337	41,878 Added 36.11%	157,851 $1.89 Million
Q1 2021 May 17, 2021	SELL	$10.88 - $17.05 $576,574 - $903,547	-52,994 Reduced 31.36%	115,973 $1.45 Million
Q4 2020 Feb 16, 2021	SELL	$9.23 - $18.18 $3.52 Million - $6.94 Million	-381,765 Reduced 69.32%	168,967 $2.64 Million
Q3 2020 Nov 16, 2020	BUY	$9.38 - $12.48 $5.17 Million - $6.87 Million	550,732 New	550,732 $5.2 Million
Q2 2020 Aug 14, 2020	SELL	$6.21 - $11.83 $9.24 Million - $17.6 Million	-1,488,020 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$5.05 - $8.85 $7.51 Million - $13.2 Million	1,488,020 New	1,488,020 $9.48 Million
Q2 2019 Aug 14, 2019	SELL	$8.75 - $13.03 $95,217 - $141,792	-10,882 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$7.72 - $12.81 $84,009 - $139,398	10,882 New	10,882 $104,000
Q4 2018 Feb 14, 2019	SELL	$9.51 - $16.6 $4.42 Million - $7.72 Million	-464,840 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$13.05 - $19.05 $5.85 Million - $8.53 Million	447,932 Added 2649.23%	464,840 $7.88 Million
Q2 2018 Aug 14, 2018	SELL	$13.9 - $19.8 $1.08 Million - $1.54 Million	-77,756 Reduced 82.14%	16,908 $240,000
Q1 2018 May 15, 2018	SELL	$16.7 - $26.35 $3.04 Million - $4.8 Million	-182,127 Reduced 65.8%	94,664 $1.8 Million
Q4 2017 Feb 14, 2018	SELL	$11.6 - $17.35 $7.72 Million - $11.5 Million	-665,306 Reduced 70.62%	276,791 $4.54 Million
Q3 2017 Nov 14, 2017	BUY	$8.4 - $15.0 $7.91 Million - $14.1 Million	942,097	942,097 $14.1 Million

Others Institutions Holding SGMO

# of Institutions

125

Shares Held

50.6M

Call Options Held

1.1M

Put Options Held

789K

View Full List

About SANGAMO THERAPEUTICS, INC

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $81.4M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

More about SGMO

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account